114 related articles for article (PubMed ID: 16835344)
1. A multiplex tissue immunoblotting assay for proteomic profiling: a pilot study of the normal to tumor transition of esophageal squamous cell carcinoma.
Chung JY; Braunschweig T; Hu N; Roth M; Traicoff JL; Wang QH; Knezevic V; Taylor PR; Hewitt SM
Cancer Epidemiol Biomarkers Prev; 2006 Jul; 15(7):1403-8. PubMed ID: 16835344
[TBL] [Abstract][Full Text] [Related]
2. Ki-67 and ProExC are useful immunohistochemical markers in esophageal squamous intraepithelial neoplasia.
Wang WC; Wu TT; Chandan VS; Lohse CM; Zhang L
Hum Pathol; 2011 Oct; 42(10):1430-7. PubMed ID: 21420715
[TBL] [Abstract][Full Text] [Related]
3. p53 Gene mutation and genetic instability in superficial multifocal esophageal squamous cell carcinoma.
Fujiki T; Haraoka S; Yoshioka S; Ohshima K; Iwashita A; Kikuchi M
Int J Oncol; 2002 Apr; 20(4):669-79. PubMed ID: 11894109
[TBL] [Abstract][Full Text] [Related]
4. Expression of cyclooxygenase-1 and cyclooxygenase-2 in human esophageal mucosa, dysplasia and carcinoma.
Kase S; Osaki M; Honjo S; Hashimoto K; Adachi H; Tsujitani S; Ito H
Pathobiology; 2004; 71(2):84-92. PubMed ID: 14707443
[TBL] [Abstract][Full Text] [Related]
5. Expression of p53-related protein p63 in the gastrointestinal tract and in esophageal metaplastic and neoplastic disorders.
Glickman JN; Yang A; Shahsafaei A; McKeon F; Odze RD
Hum Pathol; 2001 Nov; 32(11):1157-65. PubMed ID: 11727253
[TBL] [Abstract][Full Text] [Related]
6. Alterations of p53, cyclin D1 and pRB expression in the carcinogenesis of esophageal squamous cell carcinoma.
Kawakubo H; Ozawa S; Ando N; Kitagawa Y; Mukai M; Ueda M; Kitajima M
Oncol Rep; 2005 Dec; 14(6):1453-9. PubMed ID: 16273238
[TBL] [Abstract][Full Text] [Related]
7. Loss of MAL expression in precancerous lesions of the esophagus.
Mimori K; Nishida K; Nakamura Y; Ieta K; Yoshikawa Y; Sasaki A; Ishii H; Alonso MA; Mori M
Ann Surg Oncol; 2007 May; 14(5):1670-7. PubMed ID: 17151798
[TBL] [Abstract][Full Text] [Related]
8. Immunohistochemical analysis of selected molecular markers in esophagus precancerous, adenocarcinoma and squamous cell carcinoma in Iranian subjects.
Allameh A; Rasmi Y; Nasseri-Moghaddam S; Tavangar SM; Sharifi R; Sadreddini M
Cancer Epidemiol; 2009 Jul; 33(1):79-84. PubMed ID: 19679052
[TBL] [Abstract][Full Text] [Related]
9. Topological analysis of p21WAF1/CIP1 expression in esophageal squamous dysplasia.
Shirakawa Y; Naomoto Y; Kimura M; Kawashima R; Yamatsuji T; Tamaki T; Hamada M; Haisa M; Tanaka N
Clin Cancer Res; 2000 Feb; 6(2):541-50. PubMed ID: 10690537
[TBL] [Abstract][Full Text] [Related]
10. DNA ploidy, P53 expression, and cellular proliferation in normal epithelium and squamous dysplasia of non-cancerous and cancerous human oesophagi.
Itakura Y; Sasano F; Date F; Kato K; Sekine H; Mori S; Nagura H
Anticancer Res; 1996; 16(1):201-8. PubMed ID: 8615609
[TBL] [Abstract][Full Text] [Related]
11. [Expression of human Sel-1-like gene and its significance in esophageal cancer].
Li H; Zhan HQ; Zhang HF
Zhonghua Bing Li Xue Za Zhi; 2007 Jun; 36(6):370-4. PubMed ID: 17822620
[TBL] [Abstract][Full Text] [Related]
12. [Expression of retinoic acid receptor-beta mRNA and p16, p53, Ki67 proteins in esophageal carcinoma and its precursor lesions].
Huang H; Wang LF; Tian HM; Liu Y; Li M; Qu P; Wang WR; Zhang W
Zhonghua Zhong Liu Za Zhi; 2005 Mar; 27(3):152-5. PubMed ID: 15946564
[TBL] [Abstract][Full Text] [Related]
13. Toll-like receptor 9 is a novel biomarker for esophageal squamous cell dysplasia and squamous cell carcinoma progression.
Takala H; Kauppila JH; Soini Y; Selander KS; Vuopala KS; Lehenkari PP; Saarnio J; Karttunen TJ
J Innate Immun; 2011; 3(6):631-8. PubMed ID: 21876325
[TBL] [Abstract][Full Text] [Related]
14. Role of p53 gene mutations in human esophageal carcinogenesis: results from immunohistochemical and mutation analyses of carcinomas and nearby non-cancerous lesions.
Shi ST; Yang GY; Wang LD; Xue Z; Feng B; Ding W; Xing EP; Yang CS
Carcinogenesis; 1999 Apr; 20(4):591-7. PubMed ID: 10223186
[TBL] [Abstract][Full Text] [Related]
15. [Dysregulation of Annexin II expression in esophageal squamous cell cancer and adjacent tissues from a high-incidence area for esophageal cancer in Henan province].
Qi YJ; Wang LD; Jiao XY; Feng XS; Fan ZM; Gao SS; He X; Li JL; Chang FB
Ai Zheng; 2007 Jul; 26(7):730-6. PubMed ID: 17626749
[TBL] [Abstract][Full Text] [Related]
16. Seprase, dipeptidyl peptidase IV and urokinase-type plasminogen activator expression in dysplasia and invasive squamous cell carcinoma of the esophagus. A study of 229 cases from Anyang Tumor Hospital, Henan Province, China.
Goscinski MA; Suo ZH; Nesland JM; Chen WT; Zakrzewska M; Wang J; Zhang S; Flørenes VA; Giercksky KE
Oncology; 2008; 75(1-2):49-59. PubMed ID: 18787344
[TBL] [Abstract][Full Text] [Related]
17. [Expression of p53 in human esophageal carcinoma and pre-malignant lesions in the esophagus].
Dong Y; Liu S
Zhonghua Zhong Liu Za Zhi; 1996 Jan; 18(1):58-60. PubMed ID: 8732116
[TBL] [Abstract][Full Text] [Related]
18. [Expression of nucleostemin mRNA and protein in the esophageal squamous cell carcinoma].
Zhang GY; Yin L; Li SL; Xing WY; Zhao QM; Le XP; Gao DL; Chen KS; Zhang YH; Zhang QX
Zhonghua Zhong Liu Za Zhi; 2008 Feb; 30(2):125-8. PubMed ID: 18646696
[TBL] [Abstract][Full Text] [Related]
19. SEL1L and squamous cell carcinoma of the esophagus.
Granelli P; Cattaneo M; Ferrero S; Bottiglieri L; Bosari S; Fichera G; Biunno I
Clin Cancer Res; 2004 Sep; 10(17):5857-61. PubMed ID: 15355917
[TBL] [Abstract][Full Text] [Related]
20. p53 expression above the basal cell layer in oral mucosa is an early event of malignant transformation and has predictive value for developing oral squamous cell carcinoma.
Cruz IB; Snijders PJ; Meijer CJ; Braakhuis BJ; Snow GB; Walboomers JM; van der Waal I
J Pathol; 1998 Apr; 184(4):360-8. PubMed ID: 9664901
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
